๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

6007 Combining clinical factors with a genomic signature (ColoPrint) for the prognosis prediction of stage II and III colon cancer patients

โœ Scribed by Simon, I.; Tollenaar, R.; Mesker, W.; Roepman, P.; Glas, A.; Salazar, R.; Capella, G.; Moreno, V.; Veer, L. van't; Bernards, R.

Book ID
123472177
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
48 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Vascular endothelial growth factor, CD68
Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma : A role for the host response in prognosis
โœ Alok A. Khorana; Charlotte K. Ryan; Christopher Cox; Shirley Eberly; Deepak M. S ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 649 KB

## Abstract ## BACKGROUND The elucidation of new therapeutic targets of prognostic significance in colon carcinoma is necessary to improve outcomes. In the current study, the authors examined the expression of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) in